By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Synergy Pharmaceuticals 

6334 Winfield Boulevard

Margate  Florida  33063  U.S.A.
Phone: 954-801-3950 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Synergy Pharma (SGYP): A Hidden Gem In The BioPharma Sector 8/16/2017 5:57:20 AM
Synergy Pharma (SGYP) Reports Second Quarter 2017 Financial Results And Business Update 8/10/2017 7:09:04 AM
Synergy Pharma (SGYP) Announces Acceptance Of Supplemental New Drug Application (sNDA) For TRULANCE (Plecanatide) For The Treatment Of Adults With Irritable Bowel Syndrome With Constipation (IBS-C) 6/7/2017 10:10:24 AM
Synergy Pharma (SGYP) Reports First Quarter 2017 Financial Results And Business Update 5/11/2017 7:22:24 AM
Synergy Pharma (SGYP) To Present Positive TRULANCE (Plecanatide) Phase III Data At Digestive Disease Week (DDW) For The Treatment Of Irritable Bowel Syndrome With Constipation (IBS-C) 5/10/2017 7:58:58 AM
Synergy Pharma (SGYP) Presents New Insights At Digestive Disease Week (DDW) Examining Patient And Physician Perceptions And Experiences With Chronic Idiopathic Constipation (CIC) 5/8/2017 6:39:20 AM
Synergy Pharma (SGYP) To Present TRULANCE (Plecanatide) Phase III Data At Digestive Disease Week (DDW) For The Treatment Of Adults With Chronic Idiopathic Constipation (CIC) With Moderate To Very Severe Bloating 5/8/2017 6:35:13 AM
Synergy Pharma (SGYP) To Highlight New Data For TRULANCE (Plecanatide) At Digestive Disease Week (DDW) 5/1/2017 8:15:02 AM
Synergy Pharma (SGYP) Appoints Gary G. Gemignani As Chief Financial Officer 4/17/2017 9:24:58 AM
Synergy Pharma (SGYP) Announces Issuance Of Three New Patents Expected To Extend TRULANCE (Plecanatide) Patent Protection Until 2032 4/12/2017 12:07:46 PM
12345678910...
//-->